Cervix:
-
GOG 219: A Phase III Randomized Trial of Weekly
Cisplantin and Radiation versus Cisplatin and Tirazamine and
Radiation in Stage IB2, IIA, IIB, IIIB and IVA Cervical
Carcinoma Limited to the Pelvis
Endometrial:
-
GOG 209: A Randomized Phase III Trial of Doxorubicin /
Cisplatin / Paclitaxel / G-CSF Versus Carboplatin /
Paclitaxel in Patients with Stage III & IV or Recurrent
Endometrial Cancer
Ovarian/Peritoneal:
-
GOG 212: A Randomized Phase III Trial of Maintenance
Chemotherapy Comparing 12, Monthly Cycles of Single Agent
Paclitaxel or XyotaxTM (CT-2103) (IND# 70177), Versus No
Treatment Until Documented Relapse in Women with Advanced
Ovarian or Primary Peritoneal Cancer Who Achieve a Complete
Clinical Response to Primary Platinum/Taxane Chemotherapy
-
GOG 218: A Phase III Trial of Carboplatin and Paclitaxel
Plus Placebo Versus Carboplatin and Paclitaxel Plus
Concurrent Bevacizumab (IND #7921) Followed by Placebo,
Versus Carboplatin and Paclitaxel Plus Concurrent and
Extended Bevacizumab, in Women with Newly Diagnosed,
Previously Untreated, Suboptimal Advanced Stage Epithelial
Ovarian and Primary Peritoneal Cancer
Vulva:
For more information on the above clinical
trials:
Cheryl Patz, RN, OCN, CCRC, 360.715.4133
Return to previous page
|